BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$15.27
+19.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.40x
- Price / sales
- 1.53x
- Price / cash flow
- -0.79x
Enterprise value
- Enterprise value
- $8.1M
- EV / sales
- 1.36x
- EV / EBITDA
- -0.55x
- EV / EBIT
- -0.65x
- Market cap
- $9.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026